Can Cialis (tadalafil) improve the effectiveness of pelvic‑floor physical therapy in men with chronic prostatitis/chronic pelvic pain syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tadalafil Does Not Enhance Pelvic Floor Physical Therapy Outcomes in CP/CPPS

There is no evidence that tadalafil improves the effectiveness of pelvic floor physical therapy in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). While tadalafil can modestly improve some CP/CPPS symptoms when used alone, and pelvic floor therapy addresses the neuromuscular dysfunction underlying many cases, no studies have evaluated their combined use or demonstrated synergistic benefit.

Evidence for Tadalafil Monotherapy in CP/CPPS

Tadalafil 5 mg daily shows modest efficacy as a standalone treatment for CP/CPPS:

  • In a randomized placebo-controlled trial of 140 men ≤45 years with moderate-to-severe CP/CPPS, tadalafil 5 mg daily for 6 weeks significantly improved total NIH-CPSI scores, urinary symptoms, and quality of life compared to baseline 1
  • However, pain scores did not significantly differ from placebo (10.42 vs 11.71, p>0.05), which is the hallmark symptom of CP/CPPS 1
  • Only 50.8% of patients achieved a clinically significant response (≥25% reduction in total CPSI score) 1
  • When compared head-to-head with cernitin pollen extract as add-on therapy to alpha-blockers, tadalafil was significantly less effective for pelvic pain relief, with only 8.9% of tadalafil patients achieving ≥50% pain reduction versus 50% with cernitin 2

Evidence for Pelvic Floor Physical Therapy in CP/CPPS

Pelvic floor dysfunction is a core pathophysiologic mechanism in CP/CPPS:

  • Men with CP/CPPS demonstrate impaired ability to relax pelvic floor muscles after contraction, particularly those with ejaculation-related pain (70% of CP/CPPS patients) 3
  • Manual physical therapy techniques including trigger point release, muscle contracture lengthening, and scar tissue release should be offered to patients with pelvic floor tenderness 4, 5
  • In two case reports, multimodal physical therapy including manual pelvic floor techniques, progressive muscle relaxation, flexibility exercises, and aerobic conditioning resulted in dramatic symptom improvement—one patient's NIH-CPSI score decreased from 25 to 0 6
  • The 2025 AUA Guideline on Male Chronic Pelvic Pain emphasizes a multimodal/multidisciplinary treatment approach that addresses neuromuscular dysfunction 7

Why Combination Therapy Lacks Evidence

No published studies have evaluated tadalafil as an adjunct to pelvic floor physical therapy. The mechanisms of action are distinct:

  • Tadalafil works through smooth muscle relaxation via the NO-cGMP pathway, potentially improving bladder neck/detrusor function and pelvic blood flow 8
  • Pelvic floor physical therapy addresses skeletal muscle hypertonicity, trigger points, and impaired neuromuscular control 3, 6
  • The FDA label for tadalafil 5 mg daily in BPH shows improvement in IPSS scores but no significant difference in objective urinary flow rates (Qmax) compared to placebo 9, suggesting limited impact on mechanical obstruction

Clinical Recommendations

For men with CP/CPPS considering treatment options:

  1. Prioritize pelvic floor physical therapy with a therapist trained in manual pelvic floor techniques if pelvic floor tenderness is present on examination 4, 5

  2. Consider tadalafil 5 mg daily as a separate intervention for patients with concomitant erectile dysfunction or predominant urinary symptoms, but do not expect it to enhance physical therapy outcomes 1, 10

  3. Implement behavioral modifications concurrently: stress management practices (meditation, imagery), dietary modification to avoid bladder irritants, and pelvic floor muscle relaxation techniques 4, 11

  4. Avoid chronic opioid therapy except after informed shared decision-making with periodic follow-ups to assess efficacy and potential for misuse 4, 11

  5. For refractory pain, consider amitriptyline starting at 10 mg and titrating to 75-100 mg if tolerated, or urinary analgesics like phenazopyridine for symptomatic relief 4, 11

Common Pitfalls

  • Do not assume tadalafil will potentiate physical therapy benefits—the evidence shows tadalafil's primary benefit is in urinary symptoms and quality of life, not pain reduction 1
  • Do not delay referral to specialized pelvic floor physical therapy while trialing medications alone—the neuromuscular dysfunction requires hands-on manual therapy 3, 6
  • Do not use combination alpha-blocker plus tadalafil 5 mg daily for LUTS/BPH, as guidelines explicitly state this offers no advantages over either agent alone 4
  • In men under 35 years, test for atypical pathogens (Chlamydia, Mycoplasma) and consider adding doxycycline 100 mg twice daily for 7 days to cover sexually transmitted causes 12

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Clobetasol Propionate and Chronic Prostatitis/Chronic Pelvic Pain Syndrome Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Tadalafil is sufficiently effective for severe chronic prostatitis/chronic pelvic pain syndrome in patients with benign prostatic hyperplasia.

International journal of urology : official journal of the Japanese Urological Association, 2020

Guideline

Pain Management in Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prostatitis: Definition, Prevalence, and Causes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.